// App-Quantinova.ai

1294 : Sensitization of malignant melanomas to TRAIL-induced apoptosis by quercetin

Researchers

Presenter

  • Katherine Turner

Principal Investigators

  • Daniel Lindner

  • Michael Kalafatis

Medical Centers

  • Cleveland State University, Cleveland, OH

  • Taussig Cancer Institute, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Refractory malignancies

  • Melanoma

  • Skin carcinoma

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

  • B-Raf proto-oncogene, serine/threonine kinase

  • GTPase Nras

Drug/Treatment

  • quercetin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved